Quick Answer
Healthcare Triangle, Inc. reported Total Revenue of $11.70 million for fiscal year 2024.
Healthcare Triangle, Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $11.70M -64.8% |
$33.20M -27.6% |
$45.89M +30.1% |
$35.27M +12.5% |
$31.34M | — |
| Net Income | -$5.97M +31.3% |
-$8.69M +9.6% |
-$9.61M -61.5% |
-$5.95M -352.8% |
$2.35M | — |
| Diluted EPS | -$1.13 +45.7% |
-$2.08 +20.9% |
-$2.63 -1202.0% |
-$0.20 -340.5% |
$0.08 | — |
| Total Assets | $1.96M -71.4% |
$6.86M -67.0% |
$20.76M -15.6% |
$24.61M +121.6% |
$11.11M | — |
| Cash and Equivalents | $20.0K -98.4% |
$1.23M -8.0% |
$1.34M -24.2% |
$1.77M +26.2% |
$1.40M +43.9% |
$974.8K |
| Stockholders Equity | -$5.11M -267.6% |
-$1.39M -123.0% |
$6.04M -62.6% |
$16.14M +272.8% |
$4.33M +119.2% |
$1.97M |
| R&D Expense | $429.0K -46.3% |
$799.0K -86.6% |
$5.95M +13.3% |
$5.26M +201.6% |
$1.74M | — |
| Operating Income | -$4.75M +38.3% |
-$7.70M +26.1% |
-$10.42M -94.4% |
-$5.36M -555.3% |
$1.18M | — |
| Shares Outstanding | 5.67M +31.5% |
4.31M +3.3% |
4.17M -88.2% |
35.26M +26.4% |
27.90M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $3.49M | +44.6% | -1.9% |
| Net Income | September 30, 2025 | -$1.91M | -52.6% | -39.3% |
| Diluted EPS | September 30, 2025 | -$0.42 | +99.2% | +27.6% |
| Total Assets | September 30, 2025 | $13.84M | +190.3% | -5.0% |
| Cash and Equivalents | September 30, 2025 | $1.63M | +5717.9% | -76.1% |
| Stockholders Equity | September 30, 2025 | $8.73M | +580.0% | -14.5% |
| R&D Expense | September 30, 2025 | $59.0K | -66.3% | +7.3% |
| Operating Income | September 30, 2025 | -$2.59M | -122.0% | -90.7% |
| Shares Outstanding | September 30, 2025 | 4.44M | -21.6% | -23.8% |
- Healthcare Triangle, Inc. reported Total Revenue of $11.70 million for fiscal year 2024.
- Healthcare Triangle, Inc. showed a decrease of -64.8% in Total Revenue compared to the prior fiscal year.
- Healthcare Triangle, Inc. reported Net Income of -$5.97 million for fiscal year 2024.
- Healthcare Triangle, Inc. showed an increase of +31.3% in Net Income compared to the prior fiscal year.
- Healthcare Triangle, Inc. reported Diluted EPS of $1.13 per share (loss) for fiscal year 2024.
- Healthcare Triangle, Inc. showed an increase of +45.7% in Diluted EPS compared to the prior fiscal year.
- Healthcare Triangle, Inc. reported Total Assets of $1.96 million for fiscal year 2024.
- Healthcare Triangle, Inc. showed a decrease of -71.4% in Total Assets compared to the prior fiscal year.
- Healthcare Triangle, Inc. reported Cash and Equivalents of $20.0 thousand for fiscal year 2024.
- Healthcare Triangle, Inc. showed a decrease of -98.4% in Cash and Equivalents compared to the prior fiscal year.
- Healthcare Triangle, Inc. reported Stockholders Equity of -$5.11 million for fiscal year 2024.
- Healthcare Triangle, Inc. showed a decrease of -267.6% in Stockholders Equity compared to the prior fiscal year.
- Healthcare Triangle, Inc. reported R&D Expense of $429.0 thousand for fiscal year 2024.
- Healthcare Triangle, Inc. showed a decrease of -46.3% in R&D Expense compared to the prior fiscal year.
- Healthcare Triangle, Inc. reported Operating Income of -$4.75 million for fiscal year 2024.
- Healthcare Triangle, Inc. showed an increase of +38.3% in Operating Income compared to the prior fiscal year.
- Healthcare Triangle, Inc. reported Shares Outstanding of 5.67 million shares for fiscal year 2024.
- Healthcare Triangle, Inc. showed an increase of +31.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: